| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +1783226.62% |
| VRNA | Verona Pharma Plc | $77.75B | +1247578.96% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +1047583.39% |
| ARGX | Argen X SE | $54.32B | +871671.39% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +627921.73% |
| ONC | BeiGene Ltd | $34.73B | +557282.95% |
| RVMD | Revolution Medicines Inc | $30.63B | +491402.86% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +378204.95% |
| BNTX | BioNTech SE | $23.52B | +377317.18% |
| INSM | Insmed Inc | $23.04B | +369609.20% |
| ROIV | Roivant Sciences Ltd | $21.31B | +341848.01% |
| INCY | Incyte Corp | $19.46B | +312238.98% |
| MRNA | Moderna Inc | $18.90B | +303223.18% |
| GMAB | Genmab | $17.06B | +273608.68% |
| ASND | Ascendis Pharma A/S | $15.18B | +243497.30% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +235883.09% |
| SMMT | Summit Therapeutics Inc | $13.47B | +216091.26% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +208567.33% |
| EXEL | Exelixis Inc | $12.69B | +203589.95% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +203544.82% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +195018.27% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +193423.02% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +178090.59% |
| ABVX | Abivax | $10.29B | +164975.36% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +162359.20% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +159567.60% |
| CYTK | Cytokinetics Inc | $9.51B | +152523.29% |
| KRYS | Krystal Biotech Inc | $9.03B | +144752.20% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +135466.23% |
| IBRX | ImmunityBio Inc | $8.26B | +132511.77% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +130475.02% |
| TECH | Bio-Techne Corp | $7.53B | +120689.92% |
| MTSR | Metsera Inc | $7.40B | +118728.64% |
| PCVX | Vaxcyte Inc | $7.36B | +118059.54% |
| CORT | Corcept Therapeutics Inc | $6.96B | +111602.56% |
| MRUS | Merus N.V | $6.83B | +109437.58% |
| IMVT | Immunovant Inc | $6.81B | +109244.40% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +107649.74% |
| ACLX | Arcellx Inc | $6.67B | +106873.82% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +105248.49% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +104119.09% |
| CELC | Celcuity Inc | $6.48B | +103843.54% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +100315.42% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +98651.60% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +96691.26% |
| TGTX | TG Therapeutics Inc | $6.00B | +96207.66% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +95346.08% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +95062.86% |
| COGT | Cogent Biosciences Inc | $5.89B | +94476.48% |
| PTCT | PTC Therapeutics Inc | $5.86B | +93883.34% |
| APGE | Apogee Therapeutics Inc | $5.82B | +93332.30% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +91640.41% |
| BLTE | Belite Bio Inc | $5.59B | +89604.52% |
| CGON | Cg Oncology Inc | $5.35B | +85770.00% |
| LEGN | Legend Biotech Corp | $5.26B | +84390.23% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +84130.05% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +83477.86% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +82699.15% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +75817.36% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +75720.34% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +72183.92% |
| TVTX | Travere Therapeutics Inc | $4.41B | +70722.43% |
| AKRO | Akero Therapeutics Inc | $4.38B | +70192.08% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +69662.71% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +68334.77% |
| ERAS | Erasca Inc | $3.88B | +62097.65% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +62077.44% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +61310.61% |
| VKTX | Viking Therapeutics Inc | $3.67B | +58782.82% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +58078.55% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +57751.39% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +52853.06% |
| BEAM | Beam Therapeutics Inc | $3.28B | +52479.79% |
| DNLI | Denali Therapeutics Inc | $3.21B | +51356.54% |
| RCUS | Arcus Biosciences Inc | $3.01B | +48175.71% |
| DYN | Dyne Therapeutics Inc | $3.00B | +48044.46% |
| ORKA | ARCA biopharma Inc | $2.91B | +46586.74% |
| TNGX | Tango Therapeutics Inc | $2.83B | +45360.26% |
| GPCR | Structure Therapeutics Inc | $2.81B | +44995.77% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +43896.46% |
| RLAY | Relay Therapeutics Inc | $2.73B | +43715.33% |
| ALMS | Alumis Inc | $2.67B | +42704.92% |
| IRON | Disc Medicine Inc | $2.66B | +42654.15% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +42340.76% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +41365.40% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +41181.95% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +40363.71% |
| IMNM | Immunome Inc | $2.50B | +40055.25% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +39609.98% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +39209.26% |
| ETNB | 89bio Inc | $2.34B | +37499.19% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +36797.82% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +35481.58% |
| KOD | Kodiak Sciences Inc | $2.18B | +34901.06% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +33711.35% |
| ZLAB | Zai Lab Ltd | $2.08B | +33199.69% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +32512.15% |
| MESO | Mesoblast Ltd | $2.02B | +32287.08% |
| TYRA | Tyra Biosciences Inc | $1.97B | +31556.15% |
| SION | Sionna Therapeutics Inc | $1.96B | +31315.85% |
| STOK | Stoke Therapeutics Inc | $1.96B | +31313.01% |
| NBTX | Nanobiotix | $1.94B | +30979.79% |
| AAPG | Ascentage Pharma Group International | $1.93B | +30914.47% |
| PHVS | Pharvaris NV | $1.92B | +30784.83% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +30624.02% |
| GLPG | Galapagos NV | $1.90B | +30363.11% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +30212.35% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +29899.53% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +29677.43% |
| ADMA | Adma Biologics Inc | $1.84B | +29423.69% |
| NVAX | Novavax Inc | $1.82B | +29162.40% |
| ZYME | Zymeworks BC Inc | $1.81B | +28982.17% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +28888.76% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +28465.19% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +28279.45% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +28159.09% |
| VCEL | Vericel Corp | $1.75B | +27953.45% |
| OCS | Oculis Holding AG | $1.74B | +27890.43% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +27764.62% |
| BHVN | Biohaven Ltd | $1.70B | +27168.80% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +27154.86% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +26893.98% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +26865.99% |
| ANAB | AnaptysBio Inc | $1.67B | +26776.72% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +26605.33% |
| ABCL | AbCellera Biologics Inc | $1.65B | +26434.55% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +26408.52% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +26257.43% |
| INVA | Innoviva Inc | $1.63B | +26112.10% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +25878.50% |
| NKTR | Nektar Therapeutics | $1.62B | +25861.23% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +25840.50% |
| QURE | uniQure N.V. | $1.59B | +25360.67% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +25243.28% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +25005.25% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +24867.79% |
| PGEN | Precigen Inc | $1.55B | +24806.42% |
| IMTX | Immatics N.V | $1.53B | +24511.08% |
| ARDX | Ardelyx Inc | $1.52B | +24354.13% |
| MBX | MBX Biosciences Inc | $1.52B | +24237.31% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +24044.80% |
| VIR | Vir Biotechnology Inc | $1.47B | +23445.89% |
| IMCR | Immunocore Holdings plc | $1.45B | +23165.00% |
| URGN | UroGen Pharma Ltd | $1.43B | +22826.18% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +22599.77% |
| GHRS | GH Research PLC | $1.39B | +22159.67% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +21928.13% |
| SEPN | Septerna Inc | $1.34B | +21373.06% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +21338.71% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +20957.16% |
| MAZE | Maze Therapeutics Inc | $1.30B | +20692.64% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +20273.26% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +19873.74% |
| TRML | Tourmaline Bio Inc | $1.24B | +19730.73% |
| WVE | Wave Life Sciences Ltd | $1.22B | +19469.07% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +18010.25% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +17993.45% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +17524.42% |
| MNKD | Mannkind Corp | $1.10B | +17498.41% |
| DBVT | DBV Technologies | $1.10B | +17478.13% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +17348.66% |
| SVRA | Savara Inc | $1.07B | +17033.40% |
| JBIO | Jade Biosciences Inc | $1.06B | +16925.78% |
| CVAC | CureVac N.V. | $1.05B | +16739.10% |
| ANNX | Annexon Inc | $1.05B | +16697.91% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +15927.27% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +15785.24% |
| CGEM | Cullinan Oncology Inc | $953.73M | +15205.24% |
| PHAR | Pharming Group N.V. | $940.58M | +14994.33% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +14724.80% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +14565.13% |
| KURA | Kura Oncology Inc | $908.93M | +14486.42% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +14433.26% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +14149.10% |
| JANX | Janux Therapeutics Inc | $878.90M | +14004.41% |
| XNCR | Xencor Inc | $868.03M | +13830.02% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +13592.20% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +13445.21% |
| GERN | Geron Corp | $843.41M | +13434.96% |
| EVMN | Evommune Inc | $841.03M | +13396.71% |
| VOR | Vor Biopharma Inc | $840.96M | +13395.61% |
| TBPH | Theravance Biopharma Inc | $837.63M | +13342.23% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +13295.14% |
| SANA | Sana Biotechnology Inc | $825.64M | +13149.75% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +12826.58% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +12692.71% |
| OMER | Omeros Corporation | $797.02M | +12690.54% |
| ABSI | Absci Corp | $789.28M | +12566.30% |
| CMRX | Chimerix Inc | $766.03M | +12193.14% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +12120.49% |
| ANRO | Alto Neuroscience Inc | $714.55M | +11366.99% |
| ATXS | Astria Therapeutics Inc | $709.95M | +11293.19% |
| DSGN | Design Therapeutics Inc | $693.10M | +11022.76% |
| SLDB | Solid Biosciences Inc | $690.73M | +10984.75% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +10863.23% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +10738.88% |
| CRMD | CorMedix Inc | $663.22M | +10543.32% |
| IVA | Inventiva | $655.21M | +10414.79% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +10287.90% |
| CABA | Cabaletta Bio Inc | $640.38M | +10176.79% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +10164.37% |
| PRME | Prime Medicine Inc | $596.03M | +9465.02% |
| CADL | Candel Therapeutics Inc | $589.73M | +9363.83% |
| CBIO | Crescent Biopharma Inc | $573.22M | +9098.96% |
| TECX | AvroBio Inc | $573.01M | +9095.58% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +9068.33% |
| ARVN | Arvinas Inc | $570.83M | +9060.52% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +8739.75% |
| VALN | Valneva SE | $545.52M | +8654.47% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +8610.55% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +8577.33% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +8538.54% |
| MDXG | Mimedx Group Inc | $537.64M | +8528.00% |
| PRTA | Prothena Corporation plc | $532.36M | +8443.31% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +8244.47% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +7953.40% |
| XOMA | XOMA Corp | $497.12M | +7877.67% |
| STRO | Sutro Biopharma Inc | $491.87M | +7793.43% |
| OCGN | Ocugen Inc | $466.88M | +7392.42% |
| SVA | Sinovac Biotech Ltd | $464.94M | +7361.27% |
| IMMX | Immix Biopharma Inc | $462.80M | +7326.87% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +7323.80% |
| STTK | Shattuck Labs Inc | $458.03M | +7250.33% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +7147.26% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +7144.18% |
| UPB | Upstream Bio Inc | $449.51M | +7113.66% |
| AUTL | Autolus Therapeutics plc | $447.12M | +7075.33% |
| ADCT | Adc Therapeutics SA | $438.08M | +6930.30% |
| ASMB | Assembly Biosciences Inc | $435.45M | +6888.04% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +6839.48% |
| AURA | Aura Biosciences Inc | $430.49M | +6808.43% |
| OVID | Ovid Therapeutics Inc | $424.86M | +6718.04% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +6633.62% |
| IPSC | Century Therapeutics Inc | $415.14M | +6562.04% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +6462.54% |
| CMPX | Compass Therapeutics Inc | $408.80M | +6460.36% |
| CYBN | Cybin Inc | $408.43M | +6454.46% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +6379.53% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +6370.74% |
| BNTC | Benitec Biopharma Inc | $398.51M | +6295.23% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +6163.22% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +6161.68% |
| CCCC | C4 Therapeutics Inc | $389.10M | +6144.15% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +6134.15% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +6051.38% |
| RVNC | Revance Therapeutics Inc | $380.38M | +6004.23% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +5999.92% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +5951.67% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +5949.78% |
| OABI | OmniAb Inc | $374.99M | +5917.79% |
| REPL | Replimune Group Inc | $374.27M | +5906.17% |
| ALT | Altimmune Inc | $373.67M | +5896.68% |
| VSTM | Verastem Inc | $373.33M | +5891.19% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +5884.62% |
| PBYI | Puma Biotechnology Inc | $371.93M | +5868.63% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +5768.19% |
| CLLS | Cellectis | $364.91M | +5756.09% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +5743.40% |
| EDIT | Editas Medicine Inc | $349.39M | +5506.88% |
| PALI | Palisade Bio Inc | $346.56M | +5461.59% |
| RGNX | Regenxbio Inc | $345.32M | +5441.61% |
| IMRX | Immuneering Corp Class A | $344.95M | +5435.78% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +5426.46% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +5408.96% |
| FBRX | Forte Biosciences Inc | $340.15M | +5358.71% |
| IMAB | I-Mab | $339.64M | +5350.43% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +5269.00% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +5174.74% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +5140.92% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +5136.09% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +5120.37% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +5092.60% |
| SLN | Silence Therapeutics Plc | $321.20M | +5054.50% |
| RZLT | Rezolute Inc | $319.69M | +5030.35% |
| IVVD | Invivyd Inc | $319.57M | +5028.39% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +5012.22% |
| ANL | Adlai Nortye Ltd | $317.46M | +4994.48% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +4795.56% |
| SCPH | scPharmaceuticals Inc | $304.59M | +4788.02% |
| NAGE | Niagen Bioscience Inc | $304.32M | +4783.69% |
| SRZN | Surrozen Inc | $304.03M | +4778.95% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +4760.28% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +4647.30% |
| IRD | Ocuphire Pharma Inc | $295.61M | +4643.85% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +4542.96% |
| ACIU | AC Immune SA | $289.11M | +4539.64% |
| TENX | Tenax Therapeutics Inc | $288.39M | +4528.09% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +4490.45% |
| YDES | YD Bio Ltd | $278.91M | +4375.90% |
| MGNX | Macrogenics Inc | $278.39M | +4367.61% |
| FATE | Fate Therapeutics Inc | $275.57M | +4322.24% |
| CNTX | Context Therapeutics Inc | $273.80M | +4293.90% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +4275.94% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +4220.63% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +4131.82% |
| TARA | Protara Therapeutics Inc | $262.06M | +4105.57% |
| CGEN | Compugen Ltd | $260.97M | +4087.96% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +4030.41% |
| CHRS | Coherus Biosciences Inc | $256.00M | +4008.27% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +4004.62% |
| HUMA | Humacyte Inc | $255.32M | +3997.37% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +3923.10% |
| ALEC | Alector Inc | $245.37M | +3837.59% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +3789.51% |
| THRD | Third Harmonic Bio Inc | $241.86M | +3781.41% |
| CDXS | Codexis Inc | $239.96M | +3750.85% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +3703.67% |
| ADAG | Adagene Inc | $236.93M | +3702.19% |
| NKTX | Nkarta Inc | $236.88M | +3701.46% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +3639.34% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +3616.54% |
| NERV | Minerva Neurosciences Inc | $230.61M | +3600.78% |
| SLRN | Acelyrin Inc | $228.54M | +3567.65% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +3520.39% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +3502.03% |
| CRBU | Caribou Biosciences Inc | $223.96M | +3494.03% |
| KROS | Keros Therapeutics Inc | $223.18M | +3481.53% |
| RNA | Atrium Therapeutics Inc | $222.37M | +3468.61% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +3408.18% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +3393.94% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +3199.30% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +3148.81% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +3138.55% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +3121.63% |
| KRRO | Korro Bio Inc | $198.45M | +3084.77% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +3074.51% |
| DTIL | Precision Biosciences Inc | $195.87M | +3043.24% |
| IMUX | Immunic Inc | $190.70M | +2960.34% |
| QTTB | Q32 Bio Inc | $187.99M | +2916.81% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +2879.00% |
| MDWD | MediWound Ltd | $184.49M | +2860.59% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +2844.11% |
| THAR | Tharimmune Inc | $183.00M | +2836.75% |
| IFRX | InflaRx N.V. | $182.18M | +2823.57% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +2801.64% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +2763.44% |
| GALT | Galectin Therapeutics Inc | $177.81M | +2753.53% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +2684.99% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +2669.85% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +2669.79% |
| HRTX | Heron Therapeutics Inc | $172.54M | +2668.90% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +2658.38% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +2644.12% |
| SPRO | Spero Therapeutics Inc | $169.62M | +2622.07% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +2616.57% |
| THTX | Theratechnologies Inc | $167.34M | +2585.39% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +2573.79% |
| EQ | Equillium Inc | $166.29M | +2568.53% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +2546.49% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +2537.71% |
| MENS | Jyong Biotech Ltd | $164.22M | +2535.39% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +2513.97% |
| IPHA | Innate Pharma | $159.97M | +2467.19% |
| TTRX | Turn Therapeutics Inc | $157.58M | +2428.80% |
| MOLN | Molecular Partners AG | $154.89M | +2385.58% |
| VXRT | Vaxart Inc | $153.61M | +2365.14% |
| HURA | TuHURA Biosciences Inc | $151.32M | +2328.31% |
| NBP | NovaBridge Biosciences. | $150.91M | +2321.81% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +2315.33% |
| AKTX | Akari Therapeutics Plc | $148.12M | +2277.08% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +2232.66% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +2207.97% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +2198.97% |
| PROK | ProKidney Corp - Class A | $137.85M | +2112.20% |
| GNLX | Genelux Corp | $137.21M | +2101.95% |
| GUTS | Fractyl Health Inc | $136.31M | +2087.50% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +2024.21% |
| AGEN | Agenus Inc | $131.36M | +2008.03% |
| ACOG | Alpha Cognition Inc | $124.77M | +1902.22% |
| CRDF | Cardiff Oncology Inc | $123.75M | +1885.92% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +1833.44% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +1826.22% |
| SEER | Seer Inc - Class A | $115.64M | +1755.81% |
| ENGN | enGene Holdings Inc | $115.22M | +1749.06% |
| RPTX | Repare Therapeutics Inc | $113.91M | +1728.05% |
| COYA | Coya Therapeutics Inc | $111.89M | +1695.61% |
| PYXS | Pyxis Oncology Inc | $108.70M | +1644.37% |
| VANI | Vivani Medical Inc | $108.35M | +1638.78% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +1606.38% |
| HLVX | HilleVax Inc | $104.74M | +1580.83% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +1577.25% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +1570.64% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +1555.32% |
| PEPG | PepGen Inc | $103.13M | +1554.99% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +1543.35% |
| BMEA | Biomea Fusion Inc | $98.33M | +1477.94% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +1469.53% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +1468.52% |
| ICCC | Immucell Corp | $96.17M | +1443.28% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +1407.48% |
| ATHA | Athira Pharma Inc | $92.15M | +1378.82% |
| FBIO | Fortress Biotech Inc | $91.60M | +1369.91% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +1357.99% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +1339.76% |
| ANIX | Anixa Biosciences Inc | $88.68M | +1323.09% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +1313.76% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +1299.64% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +1296.92% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +1296.01% |
| PYPD | Polypid Ltd | $86.83M | +1293.48% |
| NRXS | Neuraxis Inc | $85.30M | +1268.93% |
| LPTX | Leap Therapeutics Inc | $84.76M | +1260.20% |
| CSBR | Champions Oncology Inc | $82.35M | +1221.52% |
| ACET | Adicet Bio Inc | $81.58M | +1209.19% |
| HYFT | MindWalk Holdings Corp | $79.54M | +1176.47% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +1175.48% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +1150.50% |
| FBIOP | Fortress Biotech Inc | $77.72M | +1147.24% |
| RLYB | Rallybio Corp | $76.87M | +1133.55% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +1132.06% |
| GANX | Gain Therapeutics Inc | $75.20M | +1106.88% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +1098.51% |
| XBIT | XBiotech Inc | $74.39M | +1093.80% |
| OSTX | OS Therapies Inc | $74.24M | +1091.32% |
| MCRB | Seres Therapeutics Inc | $73.19M | +1074.53% |
| SAVA | Cassava Sciences Inc. | $72.46M | +1062.86% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +1054.26% |
| EDSA | Edesa Biotech Inc | $70.82M | +1036.50% |
| BYSI | BeyondSpring Inc | $70.31M | +1028.40% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +1002.69% |
| SPRB | Spruce Biosciences Inc | $67.96M | +990.54% |
| CUE | Cue Biopharma Inc | $66.52M | +967.56% |
| IMA | Ikena Oncology Inc | $66.48M | +966.91% |
| MNOV | Medicinova Inc | $65.46M | +950.56% |
| IBIO | iBio Inc | $64.94M | +942.18% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +932.15% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +927.03% |
| IMMP | Immutep Ltd | $63.92M | +925.80% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +919.89% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +914.90% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +914.55% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +894.25% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +882.96% |
| GLTO | Galecto Inc | $60.81M | +875.87% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +850.03% |
| ANVS | Annovis Bio Inc | $57.22M | +818.21% |
| DWTX | Virios Therapeutics Inc | $57.12M | +816.60% |
| ENTX | Entera Bio Ltd | $55.48M | +790.34% |
| TIL | Instil Bio Inc | $55.21M | +785.93% |
| KZR | Kezar Life Sciences Inc | $53.76M | +762.72% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +747.85% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +745.89% |
| NBY | Stablecoin Development Corp | $52.10M | +736.06% |
| RNTX | Rein Therapeutics Inc | $51.79M | +731.19% |
| GOSS | Gossamer Bio Inc | $51.14M | +720.69% |
| MGX | Metagenomi Inc | $50.82M | +715.61% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +702.90% |
| INKT | MiNK Therapeutics Inc | $48.84M | +683.81% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +677.35% |
| XLO | Xilio Therapeutics Inc | $48.23M | +673.93% |
| CING | Cingulate Inc | $47.16M | +656.77% |
| ATYR | Atyr Pharma Inc | $46.89M | +652.45% |
| LVTX | LAVA Therapeutics NV | $45.77M | +634.53% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +633.82% |
| PSTV | Plus Therapeutics Inc | $45.56M | +631.20% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +607.55% |
| KALA | Kala Bio Inc | $43.31M | +595.10% |
| RNXT | RenovoRx Inc | $41.96M | +573.33% |
| NTRB | Nutriband Inc | $41.39M | +564.24% |
| HYPD | Eyenovia Inc | $41.14M | +560.25% |
| FGEN | FibroGen Inc | $39.31M | +530.78% |
| NNVC | NanoViricides Inc | $37.88M | +507.92% |
| VERU | Veru Inc | $37.40M | +500.15% |
| LTRN | Lantern Pharma Inc | $37.25M | +497.83% |
| INMB | INmune Bio Inc | $37.22M | +497.29% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +489.10% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +479.41% |
| GRCE | Acasti Pharma Inc | $36.05M | +478.60% |
| GBIO | Generation Bio Company | $35.97M | +477.22% |
| ABVC | ABVC BioPharma Inc | $35.82M | +474.79% |
| MURA | Mural Oncology plc | $35.34M | +467.17% |
| LITS | Lite Strategy Inc | $35.16M | +464.18% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +456.12% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +450.43% |
| DARE | Dare Bioscience Inc | $33.92M | +444.40% |
| EVAX | Evaxion Biotech A/S | $33.82M | +442.73% |
| BOLD | Boundless Bio Inc | $32.94M | +428.59% |
| SNTI | Senti Biosciences Inc | $31.46M | +404.80% |
| TVRD | Cara Therapeutics Inc | $30.96M | +396.82% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +382.30% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +381.00% |
| APLM | Apollomics Inc - Class A | $29.93M | +380.32% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +367.77% |
| SKYE | Skye Bioscience Inc | $29.10M | +367.03% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +365.99% |
| GRDX | Entero Therapeutics Inc | $28.95M | +364.64% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +358.74% |
| CRVO | CervoMed Inc | $28.15M | +351.69% |
| IGC | IGC Pharma Inc | $28.00M | +349.32% |
| DYAI | Dyadic International Inc DE | $27.40M | +339.68% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +339.18% |
| SER | AgeX Therapeutics Inc | $26.82M | +330.37% |
| PLRZ | Polyrizon Ltd | $26.52M | +325.59% |
| CELU | Celularity Inc - Class A | $26.39M | +323.49% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +323.00% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +322.37% |
| PTN | Palatin Technologies Inc | $26.08M | +318.46% |
| TPST | Tempest Therapeutics Inc | $25.68M | +312.04% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +305.44% |
| PLUR | Pluri Inc | $24.62M | +295.04% |
| MRKR | Marker Therapeutics Inc | $24.21M | +288.60% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +282.14% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +263.91% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +258.13% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +255.10% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +252.34% |
| NXTC | Nextcure Inc | $21.90M | +251.41% |
| OPT | Opthea Ltd | $21.53M | +245.50% |
| CRIS | Curis Inc | $21.11M | +238.75% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +227.00% |
| LGVN | Longeveron Inc - Class A | $19.70M | +216.18% |
| GNTA | Genenta Science SpA | $19.23M | +208.54% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +208.48% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +203.29% |
| XCUR | Exicure Inc | $17.78M | +185.38% |
| INAB | IN8bio Inc | $17.72M | +184.44% |
| PASG | Passage Bio Inc | $17.71M | +184.16% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +177.32% |
| MTVA | MetaVia Inc | $17.25M | +176.81% |
| LPCN | Lipocine Inc | $17.04M | +173.51% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +165.61% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +158.64% |
| HIND | ReShape Lifesciences Inc | $15.72M | +152.30% |
| COCP | Cocrystal Pharma Inc | $15.44M | +147.80% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +147.77% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +144.55% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +140.20% |
| QNCX | Quince Therapeutics Inc | $14.89M | +139.02% |
| APLT | Applied Therapeutics Inc | $14.86M | +138.52% |
| HOOK | Hookipa Pharma Inc | $14.68M | +135.54% |
| BLRX | Bioline Rx Ltd | $14.66M | +135.33% |
| MBRX | Moleculin Biotech Inc | $14.57M | +133.79% |
| IOBT | IO Biotech Inc | $14.50M | +132.67% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +130.09% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +127.02% |
| GTBP | GT Biopharma Inc | $13.91M | +123.18% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | +119.30% |
| TOVX | Theriva Biologics Inc | $13.51M | +116.75% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | +114.40% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +108.95% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | +108.45% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | +105.08% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | +97.93% |
| CALC | CalciMedica Inc | $11.72M | +88.16% |
| LNAI | Lunai Bioworks Inc | $11.72M | +88.01% |
| TRAW | Traws Pharma Inc | $11.70M | +87.72% |
| INTS | Intensity Therapeutics Inc | $11.33M | +81.83% |
| BIVI | BioVie Inc - Class A | $11.16M | +79.12% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | +78.80% |
| BRTX | BioRestorative Therapies Inc | $11.03M | +77.00% |
| APRE | Aprea Therapeutics Inc | $10.96M | +75.88% |
| KAPA | Kairos Pharma Ltd | $10.68M | +71.46% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | +67.32% |
| CVM | Cel-Sci Corp | $10.15M | +62.82% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | +62.51% |
| MLEC | Moolec Science SA | $10.06M | +61.40% |
| BCDA | BioCardia Inc | $9.85M | +58.07% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | +57.37% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | +56.13% |
| SNGX | Soligenix Inc | $9.11M | +46.13% |
| IMNN | Imunon Inc | $9.02M | +44.79% |
| EPIX | Essa Pharma Inc | $8.93M | +43.32% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | +43.11% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | +41.19% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | +39.68% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | +37.04% |
| IMRN | Immuron Ltd | $8.36M | +34.13% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | +30.94% |
| LIMN | Liminatus Pharma Inc | $8.08M | +29.63% |
| ITRM | Iterum Therapeutics Plc | $8.06M | +29.36% |
| NCNA | NuCana plc | $7.95M | +27.55% |
| ADXN | Addex Therapeutics Ltd | $7.90M | +26.76% |
| SYBX | Synlogic Inc | $7.72M | +23.91% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | +23.00% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | +17.72% |
| XBIO | Xenetic Biosciences Inc | $7.06M | +13.37% |
| GNPX | Genprex Inc | $7.02M | +12.68% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | +12.04% |
| EVGN | Evogene Ltd | $6.91M | +10.96% |
| SILO | SILO Pharma Inc | $6.78M | +8.86% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | +8.23% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | +2.71% |
| GOVX | Geovax Labs Inc | $6.29M | +0.87% |
| APM | Aptorum Group Ltd - Class A | $6.26M | +0.39% |
| BCAB | BioAtla Inc | $6.19M | -0.66% |
| PPBT | Purple Biotech Ltd | $6.05M | -2.92% |
| APVO | Aptevo Therapeutics Inc | $5.83M | -6.50% |
| BGMS | Bio Green Med Solution Inc | $5.30M | -14.97% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | -15.74% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -16.09% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | -16.89% |
| HCWB | HCW Biologics Inc | $5.10M | -18.20% |
| PULM | Pulmatrix Inc | $4.97M | -20.29% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -21.21% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | -21.28% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | -24.90% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | -25.10% |
| ALZN | Alzamend Neuro Inc | $4.38M | -29.78% |
| MBIO | Mustang Bio Inc | $4.29M | -31.15% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -31.55% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -31.57% |
| REVB | Revelation Biosciences Inc | $4.26M | -31.63% |
| FBLG | FibroBiologics Inc | $4.23M | -32.19% |
| ENVB | Enveric Biosciences Inc | $4.15M | -33.36% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -33.59% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -34.52% |
| PHGE | BiomX Inc | $3.91M | -37.32% |
| PBM | Psyence Biomedical Ltd | $3.76M | -39.61% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -40.34% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -42.12% |
| VIVS | VivoSim Labs Inc | $3.36M | -46.01% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -46.37% |
| AZTR | Azitra Inc | $3.32M | -46.70% |
| GRI | GRI Bio Inc | $3.30M | -47.10% |
| SPRC | SciSparc Ltd | $3.05M | -51.13% |
| AFMD | Affimed N.V. | $2.98M | -52.25% |
| CMND | Clearmind Medicine Inc | $2.88M | -53.75% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -53.84% |
| ARTL | Artelo Biosciences Inc | $2.75M | -55.93% |
| OGEN | Oragenics Inc | $2.58M | -58.64% |
| PPCB | Propanc Biopharma Inc | $2.50M | -59.85% |
| NTBL | Notable Labs Inc Ord | $2.39M | -61.57% |
| BBLG | Bone Biologics Corp | $2.23M | -64.28% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -65.56% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -66.49% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -68.00% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -72.01% |
| ONCO | Onconetix Inc | $1.61M | -74.13% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -74.99% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -75.05% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -75.07% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -75.62% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -77.10% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -77.78% |
| JAGX | Jaguar Health Inc | $1.34M | -78.44% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -79.11% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -83.83% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -85.24% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -91.16% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -92.83% |
| ELAB | PMGC Holdings Inc | $221376.00 | -96.45% |
| ADTX | Aditxt Inc | $132564.52 | -97.87% |
| CDT | CDT Equity Inc | $110551.31 | -98.23% |